- Home
- HCIC vs VNDA Comparison
HCIC vs VNDA Comparison
Compare HCIC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCIC | VNDA |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.6M | 361.4M |
| IPO Year | 2026 | 2005 |
Fundamental Metrics
Financial Performance| Metric | HCIC | VNDA |
|---|---|---|
| Price | $9.97 | $5.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $14.90 |
| AVG Volume (30 Days) | 16.9K | ★ 844.1K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $216,105,000.00 |
| Revenue This Year | N/A | $21.35 |
| Revenue Next Year | N/A | $37.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.72 |
| 52 Week Low | $9.93 | $4.14 |
| 52 Week High | $10.01 | $9.91 |
Technical Indicators
Market Signals| Indicator | HCIC | VNDA |
|---|---|---|
| Relative Strength Index (RSI) | 56.67 | 30.33 |
| Support Level | N/A | $5.11 |
| Resistance Level | $9.99 | $5.58 |
| Average True Range (ATR) | 0.02 | 0.24 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 53.33 | 0.00 |
Price Performance
Historical ComparisonAbout HCIC Hennessy Capital Investment Corp. VIII Class A Ordinary Shares
Hennessy Capital Investment Corp VIII is a blank check company.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.